XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES    
Net income (loss) $ 1,121 $ (200)
Adjustments to reconcile to net cash used in operating activities:    
Depreciation 154 160
Amortization 285 303
Goodwill and other asset impairment charges 104 12
Equity earnings and charges from investment in Change Healthcare Joint Venture 0 1,450
Deferred taxes (35) (380)
Credits associated with last-in, first-out inventory method (104) (48)
Non-cash operating lease expense 172 180
Loss (gain) from sales of businesses and investments 1 (1)
Other non-cash items 17 145
Changes in assets and liabilities, net of acquisitions:    
Receivables 981 (866)
Inventories (1,396) 331
Drafts and accounts payable (1,305) (1,203)
Operating lease liabilities (185) (189)
Taxes (58) 70
Other 207 77
Net cash used in operating activities (41) (159)
INVESTING ACTIVITIES    
Payments for property, plant, and equipment (174) (126)
Capitalized software expenditures (91) (58)
Acquisitions, net of cash, cash equivalents, and restricted cash acquired (8) (95)
Proceeds from sales of businesses and investments, net 9 3
Other (14) (9)
Net cash used in investing activities (278) (285)
FINANCING ACTIVITIES    
Proceeds from short-term borrowings 5,303 8,670
Repayments of short-term borrowings (5,303) (8,122)
Repayments of long-term debt (5) (5)
Common stock transactions:    
Issuances 39 78
Share repurchases, including shares surrendered for tax withholding (272) (1,452)
Dividends paid (140) (148)
Other (23) (224)
Net cash used in financing activities (401) (1,203)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (63) 22
Net decrease in cash, cash equivalents, and restricted cash (783) (1,625)
Cash, cash equivalents, and restricted cash at beginning of period 4,023 2,981
Cash, cash equivalents, and restricted cash at end of period 3,240 1,356
Less: Restricted cash at end of period included in Prepaid expenses and other (149) 0
Cash and cash equivalents at end of period $ 3,091 $ 1,356